Who invested in Parallel Bio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Y Combinator: S21

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2025, from 1 source

Latest round: Series A, $21MJun 2025
Investors: 4

See who backed them

The rounds

Jun 2025
Series A$21M
Source recorded

Founders and team

From Parallel Bio's own website: 2 founders, 12 on the team.

Juliana HilliardCo-Founder & Co-CEO

Robert DiFazioCo-Founder & Co-CEO

Amanda MerkelsonHead of Biobanking
Jennifer LeeVP of Finance and Operations
Nate ShapiroHead of Platform
Nathan BandowHead of Technical Operations
Amr AlySenior Software Engineer
Belinda ChinStaff Software Engineer
Chris HerSenior Research Associate
Claudio BrunOperations Manager
Fatima Al-NaimiResearch Associate
Lanna AvetisyanOffice Manager
Teddy LamIT & Security Lead
Yi-Jang LinSenior Scientist

Everyone who backed them

Y CombinatorAccelerator1round

Refactor CapitalVC firm1round

AmploVC firm1round

AIX VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Parallel Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.